Improvement with rituximab in a patient with both rheumatoid arthritis and myasthenia gravis

Muscle Nerve. 2008 Oct;38(4):1343-5. doi: 10.1002/mus.21047.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Antibodies, Monoclonal / administration & dosage*
  • Antibodies, Monoclonal, Murine-Derived
  • Antirheumatic Agents / administration & dosage
  • Arthritis, Rheumatoid / complications*
  • Arthritis, Rheumatoid / drug therapy*
  • Arthritis, Rheumatoid / immunology
  • Autoantibodies / blood
  • Autoantibodies / drug effects
  • Autoantibodies / immunology
  • Azathioprine / administration & dosage
  • B-Lymphocytes / drug effects
  • B-Lymphocytes / immunology
  • Down-Regulation / drug effects
  • Down-Regulation / immunology
  • Drug Administration Schedule
  • Drug Therapy, Combination
  • Female
  • Humans
  • Immunosuppression / methods*
  • Immunosuppressive Agents / administration & dosage
  • Middle Aged
  • Myasthenia Gravis / complications*
  • Myasthenia Gravis / drug therapy*
  • Myasthenia Gravis / immunology
  • Rituximab
  • Steroids / adverse effects
  • Time Factors
  • Treatment Outcome

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Murine-Derived
  • Antirheumatic Agents
  • Autoantibodies
  • Immunosuppressive Agents
  • Steroids
  • Rituximab
  • Azathioprine